Table 3.

Current Treatments for Neurological Diseases for which Fisetin Might Have Clinical Use

Disease	Current Treatments
Alzheimer’s disease	short term symptomatic treatment only: cholinesterase inhibitors and memantine (NMDA receptor antagonist)
Huntington’s disease	short term symptomatic treatment only: anti-psychotics; anti-depressants; mood stabilizers
Ischemic stroke	tissue plasminogen activator (only useful up to 3 hr after a stroke)
Depression	anti-depressants (selective serotonin uptake inhibitors; atypical anti-depressants; tricyclic anti-depressants; monoamine oxidase inhibitors)
Diabetic neuropathy	anti-seizure medications; anti-depressants; opioid analgesics